biotech
biotech Articles
Dynavax Technologies led the bulls on Thursday with positive results from a late stage clinical trial, on another consecutive down day for the broad markets.
Published:
Last Updated:
Spring Bank Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Syndax Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Editas Medicine has filed with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO).
Published:
Last Updated:
Corvus Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
MannKind Corp. (NASDAQ: MNKD) is one of the most traded biotech companies on the market, and one of the most shorted as well. In Tuesday’s session the stock took a big downturn after the company...
Published:
Last Updated:
Akebia Therapeutics plans on raising capital, according to its most recent proposed public offering.
Published:
Last Updated:
Reata Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Audentes Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Bavarian Nordic has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Like others on Wall Street, the analysts at the specialty biotech and health care boutique firm Leerink see 2016 as a year with some uncertainty.
Published:
Last Updated:
24/7 Wall St. has collected four companies big FDA decisions coming up in the first quarter of 2016 and added some color.
Published:
Last Updated:
Baird has maintained Outperform ratings on three top companies that have reported outstanding numbers and had positive catalysts. All three could be solid additions to aggressive growth portfolios...
Published:
Last Updated:
Proteostasis Therapeutics has registered an S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated: